Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
ZEVRA THERAPEUTICS, INC. (KMPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2023 |
4
| Anderson Thomas (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 58,800 options to buy
@ $0 |
|
| 06/30/2023 |
4
| Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 1,000 shares
@ $5.4157, valued at
$5.4k
|
|
| 06/02/2023 |
4
| FAVORITO TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 05/31/2023 |
4
| Watton Corey Michael (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 400 shares
@ $5.1053, valued at
$2k
|
|
| 05/19/2023 |
4
| Bode John B (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 1,390 shares
@ $5.035, valued at
$7k
Bought 300 shares
@ $5.0391, valued at
$1.5k
Bought 1,000 shares
@ $5.0399, valued at
$5k
Bought 4,759 shares
@ $5.04, valued at
$24k
Bought 100 shares
@ $5.045, valued at
$504.5
Bought 2,451 shares
@ $5.05, valued at
$12.4k
|
|
| 05/18/2023 |
4
| Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 51 shares
@ $4.94, valued at
$251.9
Bought 2,000 shares
@ $4.9499, valued at
$9.9k
Bought 689 shares
@ $4.9495, valued at
$3.4k
|
|
| 05/11/2023 |
4
| Calder Douglas W (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 58,800 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Watton Corey Michael (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 58,800 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Saluri Joseph (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 39,200 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 49,200 options to buy
@ $0 |
|
| 05/08/2023 |
4
| FAVORITO TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 39,200 options to buy
@ $0 |
|
| 05/08/2023 |
4
| DIXON WENDY L (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 22,500 options to buy
@ $0
Granted 36,300 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Bode John B (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Granted 58,800 options to buy
@ $0 |
|
| 03/21/2023 |
4
| SEYMOUR TAMARA A (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 519 shares
@ $4.8215, valued at
$2.5k
|
|
| 03/15/2023 |
4
| Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 2,000 shares
@ $4.6089, valued at
$9.2k
|
|
| 03/13/2023 |
4
| Plooster Matthew R (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 11,000 shares
@ $4.1953, valued at
$46.1k
|
|
| 03/13/2023 |
4
| Sangiovanni Timothy J. (SVP, Corporate Controller) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 1,100 shares
@ $4.1397, valued at
$4.6k
Bought 100 shares
@ $4.135, valued at
$413.5 |
|
| 03/13/2023 |
4
| Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 1,725 shares
@ $4.15, valued at
$7.2k
|
|
| 03/13/2023 |
4
| Tierney David S (Director) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 5,000 shares
@ $4.1463, valued at
$20.7k
|
|
| 03/13/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on ZEVRA THERAPEUTICS, INC.|
Txns:
| Bought 10,000 shares
@ $4.1978, valued at
$42k
|
|
| 01/13/2023 |
4
| Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Bought 610 shares
@ $5.82, valued at
$3.6k
Bought 25 shares
@ $5.585, valued at
$139.6 |
|
| 01/13/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Bought 9,500 shares
@ $5.4399, valued at
$51.7k
|
|
| 01/11/2023 |
4
| Clifton R. LaDuane (CFO, Secretary & Treasurer) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 459,726 options to buy
@ $4.54, valued at
$2.1M
|
|
| 01/11/2023 |
4
| Mickle Christal M M (Chief Product Dev. Officer) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 300,000 options to buy
@ $4.54, valued at
$1.4M
|
|
| 01/11/2023 |
4
| Guenther Sven (Chief Scientific Officer) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 306,000 options to buy
@ $4.54, valued at
$1.4M
|
|
| 01/11/2023 |
4
| Schafer Joshua (CCO & EVP, Bus. Development) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 300,000 options to buy
@ $4.54, valued at
$1.4M
|
|
| 01/11/2023 |
4
| Pascoe Richard W (CEO) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 700,000 options to buy
@ $4.54, valued at
$3.2M
|
|
| 01/11/2023 |
4
| Sangiovanni Timothy J. (SVP, Corporate Controller) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 136,986 options to buy
@ $4.54, valued at
$621.9k
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Saluri Joseph (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 06/30/2022 |
4
| Plooster Matthew R (Director) has filed a Form 4 on KEMPHARM, INC|
Txns:
| Granted 15,000 options to buy
@ $0 |
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|